Reid Olsen

Title: Reid Olsen: Innovator in G Protein-Coupled Receptor Screening Systems

Introduction

Reid Olsen is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biochemistry, particularly in the development of innovative screening systems for G protein-coupled receptors (GPCRs). His work has implications for understanding complex cellular signaling pathways.

Latest Patents

Reid Olsen holds a patent for a G protein-coupled receptor assay platform. This platform comprises two complementary systems that equate dynamic intermolecular interactions between a receptor and transducer with more complex stimulus-response cascades in living cells. The disclosed in vitro ADSoRB method involves the forced dissociation of transducers like G protein heterotrimers from receptors, which alters receptor conformations and ligand interactions to simulate pathway activation in a cell. Additionally, the TRUPATH method measures the extent of engineered G protein heterotrimer complex dissociation, providing single transducer resolution in a cell. He has 1 patent to his name.

Career Highlights

Reid Olsen is affiliated with the University of North Carolina at Chapel Hill, where he continues to advance research in his field. His innovative approaches to GPCR screening systems have garnered attention and recognition within the scientific community.

Collaborations

Reid has collaborated with notable colleagues, including Ryan Strachan and Bryan Leo Roth. Their combined expertise contributes to the advancement of research in GPCR-related technologies.

Conclusion

Reid Olsen's work in developing G protein-coupled receptor screening systems showcases his innovative spirit and dedication to advancing biochemistry. His contributions are paving the way for future research and applications in cellular signaling.